|
| Bladder cancer development | Bladder cancer recurrence |
Category | Term | Count | % | value | Category | Term | Count | % | value |
|
GO analysis | GOTERM_CC_DIRECT | GO:0070062∼extracellular exosome | 331 | 25.5007704160246 | 6.61E − 26 | GOTERM_MF_DIRECT | GO:0005515∼protein binding | 233 | 57.2481572481572 | 5.48E − 07 |
GOTERM_CC_DIRECT | GO:0031012∼+A1 | 69 | 5.31587057010785 | 2.26E − 19 | GOTERM_CC_DIRECT | GO:0005737∼cytoplasm | 152 | 37.3464373464373 | 1.25E − 06 |
GOTERM_CC_DIRECT | GO:0005615∼extracellular space | 164 | 12.6348228043143 | 1.98E − 13 | GOTERM_CC_DIRECT | GO:0005654∼nucleoplasm | 86 | 21.1302211302211 | 1.16E − 04 |
GOTERM_BP_DIRECT | GO:0030198∼extracellular matrix organization | 46 | 3.54391371340523 | 9.99E − 13 | GOTERM_CC_DIRECT | GO:0016020∼membrane | 70 | 17.1990171990172 | 2.74E − 04 |
GOTERM_CC_DIRECT | GO:0005578∼proteinaceous extracellular matrix | 54 | 4.16024653312788 | 1.67E − 12 | GOTERM_CC_DIRECT | GO:0005829∼cytosol | 96 | 23.5872235872235 | 4.19E − 04 |
GOTERM_CC_DIRECT | GO:0005925∼focal adhesion | 67 | 5.16178736517719 | 6.60E − 12 | GOTERM_CC_DIRECT | GO:0070062∼extracellular exosome | 83 | 20.3931203931203 | 6.83E − 04 |
GOTERM_CC_DIRECT | GO:0009986∼cell surface | 82 | 6.31741140215716 | 1.84E − 11 | GOTERM_MF_DIRECT | GO:0004693∼cyclin-dependent protein serine/threonine kinase activity | 6 | 1.47420147420147 | 7.00E − 04 |
GOTERM_BP_DIRECT | GO:0007155∼cell adhesion | 73 | 5.62403697996918 | 9.83E − 11 | GOTERM_MF_DIRECT | GO:0030332∼cyclin binding | 5 | 1.22850122850122 | 7.36E − 04 |
GOTERM_CC_DIRECT | GO:0005576∼extracellular region | 175 | 13.4822804314329 | 3.89E − 10 | GOTERM_BP_DIRECT | GO:0048146∼positive regulation of fibroblast proliferation | 7 | 1.71990171990172 | 8.99E − 04 |
GOTERM_MF_DIRECT | GO:0005515∼protein binding | 711 | 54.7765793528505 | 8.26E − 10 | GOTERM_BP_DIRECT | GO:0000082∼G1/S transition of mitotic cell cycle | 9 | 2.21130221130221 | 0.001364705455254 |
GOTERM_MF_DIRECT | GO:0008201∼heparin binding | 35 | 2.69645608628659 | 3.49E − 09 | GOTERM_BP_DIRECT | GO:0048839∼inner ear development | 6 | 1.47420147420147 | 0.00158628474829 |
GOTERM_MF_DIRECT | GO:0005178∼integrin binding | 27 | 2.08012326656394 | 8.57E − 09 | GOTERM_BP_DIRECT | GO:0031581∼hemidesmosome assembly | 4 | 0.982800982800982 | 0.001745599823436 |
GOTERM_BP_DIRECT | GO:0048146∼positive regulation of fibroblast proliferation | 19 | 1.46 E + 00 | 1.38E − 08 | GOTERM_BP_DIRECT | GO:0051591∼response to cAMP | 6 | 1.47420147420147 | 0.002664403703622 |
GOTERM_BP_DIRECT | GO:0007568∼aging | 33 | 2.54237288135593 | 1.37E − 07 | GOTERM_BP_DIRECT | GO:0001525∼angiogenesis | 13 | 3.19410319410319 | 0.002731528888927 |
GOTERM_BP_DIRECT | GO:0060333∼interferon-gamma-mediated signaling pathway | 20 | 1.54083204930662 | 2.89E − 07 | GOTERM_CC_DIRECT | GO:0005615∼extracellular space | 44 | 10.8108108108108 | 0.003130126302432 |
|
KEGG pathway | KEGG_PATHWAY | hsa05166: HTLV-I infection | 49 | 3.77503852080123 | 1.54E − 08 | KEGG_PATHWAY | hsa05200: pathways in cancer | 22 | 5.4054054054054 | 0.001345594815917 |
KEGG_PATHWAY | hsa05150: Staphylococcus aureus infection | 20 | 1.54083204930662 | 1.67E − 08 | KEGG_PATHWAY | hsa04151: PI3K-Akt signaling pathway | 19 | 4.66830466830466 | 0.003848355864399 |
KEGG_PATHWAY | hsa04510: focal adhesion | 40 | 3.08166409861325 | 3.47E − 07 | KEGG_PATHWAY | hsa04923: regulation of lipolysis in adipocytes | 6 | 1.47420147420147 | 0.015090205294328 |
KEGG_PATHWAY | hsa05323: rheumatoid arthritis | 23 | 1.77195685670261 | 1.19E − 06 | KEGG_PATHWAY | hsa04110: cell cycle | 9 | 2.21130221130221 | 0.015736544810328 |
KEGG_PATHWAY | hsa05416: viral myocarditis | 18 | 1.38674884437596 | 1.41E − 06 | KEGG_PATHWAY | hsa05222: small cell lung cancer | 7 | 1.71990171990172 | 0.023482661953239 |
KEGG_PATHWAY | hsa04514: cell adhesion molecules (CAMs) | 30 | 2.31124807395993 | 2.37E − 06 | KEGG_PATHWAY | hsa00010: glycolysis/gluconeogenesis | 6 | 1.47420147420147 | 0.03037227765735 |
KEGG_PATHWAY | hsa05310: asthma | 12 | 0.924499229583975 | 1.17E − 05 | KEGG_PATHWAY | hsa03320: PPAR signaling pathway | 6 | 1.47420147420147 | 0.03037227765735 |
KEGG_PATHWAY | hsa04110: cell cycle | 26 | 2.00308166409861 | 1.49E − 05 | KEGG_PATHWAY | hsa04610: complement and coagulation cascades | 6 | 1.47420147420147 | 0.033914937801339 |
KEGG_PATHWAY | hsa04610: complement and coagulation cascades | 18 | 1.38674884437596 | 2.41E − 05 | KEGG_PATHWAY | hsa05205: proteoglycans in cancer | 11 | 2.7027027027027 | 0.036633631217231 |
KEGG_PATHWAY | hsa04612: antigen processing and presentation | 19 | 1.46379044684129 | 2.49E − 05 | KEGG_PATHWAY | hsa04921: oxytocin signaling pathway | 9 | 2.21130221130221 | 0.042657563729801 |
|